245 related articles for article (PubMed ID: 2987235)
1. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
3. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis).
Gupta RS; Chopra A; Stetsko DK
J Cell Physiol; 1986 May; 127(2):197-206. PubMed ID: 3009493
[TBL] [Abstract][Full Text] [Related]
4. Human cell mutants affected in the interaction of the 12 beta-OH group of cardiac glycosides with the digitalis receptor.
Gupta RS; Chopra A
Biochem Pharmacol; 1987 Nov; 36(22):3829-33. PubMed ID: 2825704
[TBL] [Abstract][Full Text] [Related]
5. Cross-resistance and biochemical characteristics of second-step mutants of HeLa cells resistant to cardiac glycosides.
Chopra A; Dudani AK; Gupta RS
Biochem Cell Biol; 1990 May; 68(5):852-7. PubMed ID: 2169261
[TBL] [Abstract][Full Text] [Related]
6. Development of a specific assay for cardiac glycoside-like compounds based on cross-resistance of human cell mutants.
Gupta RS; Chopra A; Trott AB
Biochem Pharmacol; 1989 Jul; 38(13):2159-68. PubMed ID: 2735954
[TBL] [Abstract][Full Text] [Related]
7. Absence of gene amplification in human cell mutants resistant to cardiac glycosides.
Dudani AK; Gupta RS
Mol Cell Biochem; 1987 Nov; 78(1):73-9. PubMed ID: 2457797
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by digoxin and SC4453 of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.
Godfraind T; Tona Lutete DN
Eur J Pharmacol; 1979 Dec; 60(4):329-36. PubMed ID: 230981
[TBL] [Abstract][Full Text] [Related]
9. Identification of an amino acid substitution in human alpha 1 Na,K-ATPase which confers differentially reduced affinity for two related cardiac glycosides.
Askew GR; Lingrel JB
J Biol Chem; 1994 Sep; 269(39):24120-6. PubMed ID: 7929066
[TBL] [Abstract][Full Text] [Related]
10. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
[TBL] [Abstract][Full Text] [Related]
11. Variant HeLa cells selected for their resistance to ouabain.
Rosenberg HM
J Cell Physiol; 1975 Feb; 85(1):135-42. PubMed ID: 1110260
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity of the Na+, K+-pump of human red blood cells to genins of cardiac glycosides.
Senn N; Lelièvre LG; Braquet P; Garay R
Br J Pharmacol; 1988 Apr; 93(4):803-10. PubMed ID: 3390651
[TBL] [Abstract][Full Text] [Related]
13. Mutants of HeLa cells resistant to ouabain and cassaine: genetic evidence for the common site of action of cardiac glycosides and erythrophleum alkaloids.
Gupta RS
Biochem Pharmacol; 1981 Nov; 30(22):3039-44. PubMed ID: 7337720
[No Abstract] [Full Text] [Related]
14. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
15. Interaction of digoxin and SC4453 with the (Na+ + K+)-ATPase from guinea-pig heart and brain.
Godfraind T; Tona Lutete N
Arch Int Pharmacodyn Ther; 1979 May; 239(1):171-2. PubMed ID: 226021
[No Abstract] [Full Text] [Related]
16. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
Haustein KO; Graumann G; Stephan B
Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
[TBL] [Abstract][Full Text] [Related]
18. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.
Dostanic-Larson I; Van Huysse JW; Lorenz JN; Lingrel JB
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15845-50. PubMed ID: 16243970
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
20. Cardiac glycosides. 6. Gitoxigenin C16 acetates, formates, methoxycarbonates, and digitoxosides. Synthesis and Na+,K+-ATPase inhibitory activities.
Hashimoto T; Rathore H; Satoh D; Hong G; Griffin JF; From AH; Ahmed K; Fullerton DS
J Med Chem; 1986 Jun; 29(6):997-1003. PubMed ID: 3012087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
